|
|
Current
Research Studies 

SMART
HEART Study
What is Smart Heart?
SMART HEART is a collaborative study between Duke University Medical Center and the University of North Carolina Hospitals examining the relationship between mental stress and coronary artery disease.
The study is designed to evaluate the benefits of exercise training and stress management programs.
This investigation builds upon previous research showing that stress-induced myocardial ischemia (temporary inadequate blood supply to the heart) is associated with adverse health outcomes, which may be improved with exercise or stress management.
Principal Investigators of Smart Heart are
Dr. James Blumenthal and Dr. Andrew Sherwood. The study is funded by the National Heart, Lung, and Blood Institute.
Who is eligible?
-
Persons with history of coronary artery disease, documented by any of the following:
-
Previous myocardial infarction (heart attack)
-
Prior coronary revascularization, such as bypass surgery, balloon angioplasty, or stent
-
Previous cardiac catheterization with more than 75% stenosis (blockage) in at least one coronary artery
-
Positive exercise treadmill test or positive
MUGA/Thallium scan in last 2 years
-
Not currently enrolled in a cardiac rehabilitation program
What does it entail?
-
General physical examination
-
Series of initial assessments (blood
pressure/ECG monitoring, imaging of the heart and arteries)
-
Random assignment to one of three groups: stress management, aerobic exercise, or usual care
-
Sixteen-week intervention followed by repeat of initial assessments
-
Annual telephone or mail contact for 5 years after study completion
What are the benefits?
Who will be working with the
participants?
The Smart Heart Research Team
at Duke University Medical Center:
Dr. James
Blumenthal , Dr.
Andrew Sherwood, Dr. Robert Waugh, Dr. Edward Coleman, Dr.
Anastasia Georgiades, Dr. Kathy Light, Kelly Diven, PA,
Michael Ellis, RDMS, RVT, Lee M. Peirson, MS, Richard Bloomer, Margaret
Stewart, Rebecca Thurston, and Stacey Schiller
The Smart Heart Research Team
at UNC Hospitals:
Dr. Alan Hinderliter and
Bobbie White, RN
For further information contact Anastasia Georgiades at (919) 681-4280 or by email at georg023@mc.duke.edu
Return to
the top of the page
The
INSPIRE Study
What is the INSPIRE Study?
The INSPIRE Study is a
collaborative study between Duke University Medical Center and Washington
University Medical School evaluating the benefits of a telephone-based
stress management and coping skills training program in people who are
awaiting a lung transplant.
The Principal Investigator of
INSPIRE is Dr. James
Blumenthal and the Medical Director is Dr. Scott Palmer.
The study is funded by the National Heart, Lung, and Blood Institute.
Who is eligible for the
INSPIRE Study?
Anyone who is listed for a
lung transplant can join the study.
What does the INSPIRE Study
involve?
Baseline Evaluation
Random Assignment to 1 of 2
Groups
12-Week Treatment
-
Stress management -
participants will receive a phone call every week for 12 weeks from an
INSPIRE interventionist to help reduce stress and learn new skills to
better cope with lung disease and upcoming transplant.
-
Usual care - participants
will continue with routine and usual treatments and will not receive
the 12 telephone training sessions.
Follow-up Evaluations
-
after 3 months
-
after transplant surgery
-
after 12 months
Who will be working with
participants?
The INSPIRE staff
interventionists are all psychologists who have been trained to work with
patients who have lung disease. Study staff includes Elizabeth
Gullette, Ph.D., Jennifer
Norten, Ph.D., Kari Merrill, Ph.D., Kelli Colgan, and Beth
Floyd.
When does INSPIRE start?
Interested participants will
be schedule for the baseline evaluation during their next Duke visit. They
will then be given their group assignment. Those assigned to the treatment
group will receive a phone call from a therapist in the next few days.
For further information,
contact the Study Coordinator, Dr.
Elizabeth Gullette, at (919) 681-3054 or by email at
gulle002@mc.duke.edu.
Return to
the top of the page
The
SMILE Study
Standard Medical Intervention
and Long-term Exercise for the Treatment of Depression in Adults Aged 50+
The SMILE Study was designed
to investigate exercise as a treatment for depression in middle-aged and
older adults. After a series of assessments, eligible participants are
randomly assigned to one of four treatment groups: (1) Supervised
Exercise; (2)Home-based Exercise; (3) Medication (Zoloft); or (4) Placebo
("sugar pill"). The treatments are four months in duration and
are offered free of charge.
Eligible participants must
be:
50 years of age or older.
Not currently taking antidepressant medication (or, willing to come off
medication for the study).
Not currently exercising.
Willing to be randomly assigned to the treatment groups.
Benefits of participation
include:
Free assessments
A free 4-month treatment program
$100 compensation upon completion of the study
An opportunity to improve your health and contribute to science
For more information about
this study, contact the study coordinator, Dr.
Alisha Hart, at (919) 681-2612.
Return to
the top of the page
The
DISCOVER Study
The DISCOVER study
(Determinants of Improved Survival with Compromised Ventricular Ejection
Response) is a prospective study of the prognostic significance of
biobehavioral factors in patients with Congestive Heart Failure (CHF). The
study is collaboration between Duke University
Medical Center and the University of North
Carolina at Chapel Hill. The study is funded by the National
Institutes of Health.
The DISCOVER study is designed
to evaluate how a broad range of factors, from the structure and function
of the heart, to how patients feel about their life, might be linked to
CHF and its progression.
DISCOVER Research Team
Andrew Sherwood,
Ph.D, James
Blumenthal, Ph.D., Alan Hinderliter, M.D., Christopher O’Connor,
M.D., Kirk Adams, M.D., Lana
Watkins, Ph.D., Robert Waugh, M.D., Kristy
Johnson, MPH.
Michael Ellis, RDMS, RVT
Michael Ellis is an ultrasound
imaging specialist. He received his BA in Sociology from SUNY at Oswego in
1978 and has been involved in health care settings since 1985. Mr. Ellis
has worked as a Radiologic Technologist and was also educated in the
Diagnostic Medical Sonography program through Hudson Valley Community
College in Troy, New York. He has worked as a Sonographer since 1993 and
has Registries in Abdominal, Vascular and Ob/Gyn and has 6 years
experience performing Echocardiograms.
Allyson Whyte, BA
Allyson Whyte is a Data
Technician and research assistant for the DISCOVER study. She received her
Bachelors from Washington University and recently completed a pre-medical
program at Bryn Mawr College.
Return to
the top of the page
Enhancing Recovery in Coronary Heart Disease
(ENRICHD)
The ENRICHD project is a large multi-site clinical trial examining
the effects of cognitive-behavioral treatment on depression and social
isolation in post-myocardial infarction patients. Also participating
in the study are Yale and Harvard Universities, Stanford University,
Rush Presbyterian Hospital, University of Miami, University of
Washington, University of Alabama at Birmingham, and Washington
University at St. Louis. For more information regarding this research
please contact Kathryn
Lewandowski at (919) 684-5254.
Return to
the top of the page
Return to
the top of the page
|